TipRanks
Advertisement

EAFH - ETF AI Analysis

Compare

Top Page

EAFH

Xtrackers MSCI EAFE 50% Hedged Equity ETF (EAFH)

Rating:67Neutral
Price Target:―
EAFH, the Xtrackers MSCI EAFE 50% Hedged Equity ETF, earns a solid overall rating largely because it holds several high-quality global leaders like Novartis, HSBC, and AstraZeneca, which show strong financial performance, healthy profitability, and supportive earnings call sentiment. The presence of other stable blue-chip names such as ASML, Nestlé, Siemens, and Roche further supports the fund, though some holdings face valuation concerns, mixed technical signals, or growth challenges, and the concentration in large non-U.S. financials and pharmaceuticals is a key risk if those sectors or regions weaken.
Positive Factors
Strong Leading Holding
ASML, the fund’s largest position, has shown strong performance, giving a solid boost to overall returns.
Broad International Diversification
The ETF spreads its investments across many developed markets like Japan, the UK, Europe, and Asia-Pacific, helping reduce country-specific risk.
Low Expense Ratio
The fund charges relatively low fees, which helps investors keep more of the returns generated by the portfolio.
Negative Factors
Small Asset Base
The ETF manages a relatively modest amount of assets, which can sometimes lead to lower trading liquidity for investors.
Mixed Performance Among Top Holdings
Several major positions such as AstraZeneca, Nestlé, and SAP have shown weaker recent performance, which can drag on the fund’s overall results.
Heavy Exposure to Financials and Broad Market Cyclicals
A sizable allocation to financials and economically sensitive sectors means the fund may be more affected by global economic slowdowns or market stress.

EAFH vs. SPDR S&P 500 ETF (SPY)

EAFH Summary

Xtrackers MSCI EAFE 50% Hedged Equity ETF (EAFH) is an international stock fund that follows the MSCI EAFE 50% Hedged to USD Index. It invests in many large companies across Europe, Japan, and other developed markets outside the U.S. and Canada, giving broad global diversification. Well-known holdings include Nestlé, HSBC, Shell, and Novartis. The fund also hedges about half of its currency exposure, which can help reduce the impact of foreign exchange swings on U.S. investors. A key risk is that international stocks can still go up and down with global markets and may underperform U.S. stocks at times.
How much will it cost me?This ETF has an expense ratio of 0.20%, which means you’ll pay about $2 per year for every $1,000 you invest. That’s slightly higher than the cheapest plain index ETFs because this fund adds a partial currency hedge, but it’s still reasonably low-cost for a specialized international strategy.
What would affect this ETF?This ETF could benefit if developed markets in Europe and Asia grow steadily, global trade remains strong, and large companies in sectors like technology, health care, and financials continue to perform well, with the partial currency hedge helping reduce the impact of big swings between the U.S. dollar and foreign currencies. On the downside, it may be hurt by economic slowdowns or banking stress in those regions, tighter regulations or political tensions affecting major holdings like ASML, HSBC, and Shell, or sharp moves in interest rates that weigh on international stocks and financial firms.

EAFH Top 10 Holdings

This ETF leans on a global mix of developed-market heavyweights, with Europe and Japan doing most of the talking. ASML is the clear engine, rising on the back of strong demand for chip-making equipment, while Shell and Mitsubishi UFJ add extra lift from energy and financials. Health care names like Roche and Novartis are steady contributors, though AstraZeneca is losing steam and Nestlé has been lagging, slightly weighing on results. Overall, the fund is broadly diversified across sectors, with no single stock dominating the story.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV3.27%$161.45K€611.79B91.13%
76
Outperform
HSBC Holdings1.51%$74.67K£239.17B40.44%
80
Outperform
Roche Holding AG1.43%$70.71K$344.30B21.61%
73
Outperform
Shell (UK)1.36%$67.01K£216.18B40.71%
73
Outperform
Novartis AG1.26%$62.00KCHF218.02B13.47%
80
Outperform
AstraZeneca1.15%$56.56K$246.54B-6.13%
80
Outperform
Nestlé SA1.12%$55.35KCHF195.59B-0.68%
71
Outperform
Mitsubishi UFJ Financial Group1.11%$54.69K¥38.71T52.68%
76
Outperform
Siemens1.06%$52.42K€207.41B8.00%
74
Outperform
SAP SE1.04%$51.47K€223.54B-17.36%
66
Neutral

EAFH Technical Analysis

Technical Analysis Sentiment
Negative
Last Price―
Price Trends
50DMA
100DMA
200DMA
Market Momentum
MACD
RSI
STOCH
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EAFH, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EAFH.

EAFH Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$4.92M0.20%
67
Neutral
――$95.71M0.55%
66
Neutral
――$28.27M0.55%
68
Neutral
――$23.79M―
66
Neutral
――$21.06M0.27%
65
Neutral
――$5.65M0.32%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EAFH
Xtrackers MSCI EAFE 50% Hedged Equity ETF
24.92
-0.12
-0.48%
QUIZ
Zacks Quality International ETF
―
―
―
JIDE
JPMorgan International Dynamic ETF
―
―
―
TACN
T. Rowe Price Active Core International Equity ETF
―
―
―
ENHI
iShares Enhanced International Active ETF
―
―
―
REFA
Columbia Research Enhanced International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement